There’s been some back and forth between me and some members of the UK Parliament and others in the UK on the issue of mitochondrial transfer or 3-person IVF technology. Some of this has involved the UK equivalent of the Surgeon General, Professor Dame Sally Davies, who at one point apparently called my views “bunk”. I […]
Red flags in Sally Davies letter on 3-person IVF mitochondrial transfer Read More »
What is one to do when the equivalent of the Surgeon General of the UK calls one’s concerns about something, in this case 3-person IVF, “bunk”? It sure gave me some pause. What’s going on? First, some brief background. The debate over 3-person IVF/mitochondrial transfer technology has been getting more heated. The epicenter for the discussion
UK Surgeon General Calls My Concerns on 3-person IVF “Bunk” Read More »
How much do these stem cell treatments cost? Stem cell treatments of various kinds are now widely available in America at more than 100 stem cell clinics offering non-FDA approved interventions for dozens of conditions. American patients are often recruited on the Internet to travel around the US or to Mexico and other countries. How
How Much Do Stem Cell Treatments Really Cost? Read More »
Here’s some thought-provoking weekend reading. ALEXEY. CLINICAL CELL PROCESSING NEWS – PART 1, 2015 BIOPOLITICAL TIMES. MITOCHONDRIAL MISSION CREEP AND THE CLONING CONNECTION CALIFORNIA STEM CELL REPORT. CALIFORNIA’S BOB KLEIN PROPOSES $100 BILLION, INTERNATIONAL STEM CELL/GENOMICS VENTURE CARL ZIMMER. A NEW THEORY ON HOW NEANDERTHAL DNA SPREAD IN ASIA DN LEE. YOU SHOULD KNOW: MICHELLE HUNTER AND EXPLORING NEUROSCIENCE THROUGH
Super Science Weekend Reading Read More »
23andMe CEO, Anne Wojcicki, just emailed 23andMe customers (me included) with the big news that the FDA has approved the company to offer Bloom syndrome carrier status reporting. As Wojcicki points out, this is the first time ever that the FDA has granted authorization of a direct-to-consumer genetic test. This is a huge deal. Why
Landmark decision: FDA Approves 23andMe Genetic Test Read More »
I’ve seen many crazy things over the years doing this blog. There was the Moriguchi IPS cell fraud, the electric stem cell bra, the stem cell supermodel case, the stem cell soup No. 7 aphrodisiac, the STAP cell scandal….and the craziness goes on. Today there’s a new one that even surprised me. Haruko Obokata, lead STAP
Haruko Obokata 小保方 晴子-like Game Character Conducts ‘Dangerous Research’ Read More »
By Aaron Goldman Much like the winter weather we’ve been enduring on the east coast, cancer research is advancing at a rapid clip! For decades, researchers have considered pools of “cancer stem cells” (CSC) as the subsets within a tumor which both initiate progression and underpin the failure of therapy. Over the past 5 years,
Dr. Christopher Fasano, principal investigator at the Neural Stem Cell Institute and creator and host of THE Stem Cell Podcast founded a unique stem cell meeting in 2013. In this short interview I find out about The Next-Gen Stem Cell Conference (to be held this year on May 6-7) and how it differs from the
The Scoop on Cool Next-Gen Stem Cell Conference Read More »
A cool new paper is out in Stem Cell Reports describing long-term tumorigenicity of human induced pluripotent stem cells (IPSC or IPS cells). See graphical abstract. The potential tumorigenicity of IPSC is a major concern when teams around the world are translating IPSC technology to the bedside. Past studies including one from my own lab have
Lessons from New IPS Cell Study Showing Tumors Read More »
The still mysterious BioGatekeeper had challenged Yamanaka’s IPS cell patent claiming that it was obvious. The potential implications were huge given the commercial interest in translating IPS cell technology. For background see here, here, and here. There’s pretty much zero information on BioGatekeeper otherwise. Despite the potential seriousness of this patent challenge, just a few days
Challenge of Yamanaka Patent by BioGatekeeper Fails Read More »